Foster Dykema Cabot & Partners, LLC Edwards Lifesciences Corp Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 202 shares of EW stock, worth $13,782. This represents 0.0% of its overall portfolio holdings.
Number of Shares
202
Previous 156
29.49%
Holding current value
$13,782
Previous $14.9 Million
25.17%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding EW
# of Institutions
1,417Shares Held
470MCall Options Held
2.44MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA53.6MShares$3.66 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.48 Billion0.11% of portfolio
-
State Street Corp Boston, MA26MShares$1.77 Billion0.11% of portfolio
-
Alliancebernstein L.P. New York, NY20.3MShares$1.39 Billion0.68% of portfolio
-
Wellington Management Group LLP Boston, MA16.9MShares$1.15 Billion0.29% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $42.2B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...